Pharmaceutical Access and Innovation: Challenges and issues

Harvey Bale
Additional contact information
Harvey Bale: IIFMPM, Geneva, Switzerland

Development, 1999, vol. 42, issue 4, 84-86

Abstract: Harvey Bale argues that the concern about the ‘public health’ impact of trade agreements increasing patent protection in the pharmaceutical sector is contradicted by the empirical evidence that such protection had already rapidly advanced for over a decade in developing countries, without evidence of harm; and pharmaceutical-targeted compulsory licensing measures, in the few instances where they had existed, have been repealed. Development (1999) 42, 84–86. doi:10.1057/palgrave.development.1110091

Date: 1999
References: Add references at CitEc
Citations:

Downloads: (external link)
http://www.palgrave-journals.com/development/journal/v42/n4/pdf/1110091a.pdf Link to full text PDF (application/pdf)
http://www.palgrave-journals.com/development/journal/v42/n4/full/1110091a.html Link to full text HTML (text/html)
Access to full text is restricted to subscribers.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:pal:develp:v:42:y:1999:i:4:p:84-86

Ordering information: This journal article can be ordered from
http://www.springer. ... es/journal/41301/PS2

Access Statistics for this article

Development is currently edited by Stefano Prato

More articles in Development from Palgrave Macmillan, Society for International Deveopment Contact information at EDIRC.
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().